Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eylea
Pharma
Bayer projects Xarelto's sales decline will gain steam in 2025
After Xarelto saw a sales decline of 600 million euros last year because of generic competition, Bayer is projecting a sharper fall in 2025.
Kevin Dunleavy
Mar 5, 2025 11:17am
With biosim sales up 16%, Amgen expects another boost in 2025
Feb 5, 2025 11:28am
Regeneron lays out bright future for newest blockbuster Libtayo
Feb 4, 2025 11:28am
UK watchdog reaffirms Bayer's claims of misleading Roche promos
Jan 31, 2025 11:20am
Roche's Vabysmo crosses $4B mark as Polivy joins blockbuster club
Jan 30, 2025 11:06am
JPM25: Regeneron has few answers for declining sales of Eylea HD
Jan 14, 2025 10:25am
